Search - tctmd.com

Displaying 541 - 560 of 1006

Sort: Relevancy | Date

Presentation TCT 2016

TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Presenter: Michael J. Cowley, Franz-Josef Neumann, Shunsuke Kubo

October 31, 2016

Presentation TCT 2016

TCT 51: In-Hospital and One-Month Outcomes of 983 Patients Implanted With Bioresorbable Vascular Scaffolds for Acute Coronary Syndroms; Subgroup of the Prospective, All Comers, Controlled, Multicenter, FRANCE ABSORB Registry

Presenter: Michael J. Cowley, Franz-Josef Neumann, Joel Sainsous

October 31, 2016

Presentation TCT 2016

TCT 50: Impact of a Bifurcation Culprit Lesion in ST Elevation Myocardial Infarction: Procedural Success, Clinical Outcome, and Five-Year Follow-up

Presenter: Michael J. Cowley, Franz-Josef Neumann, Pablo Salinas

October 31, 2016

Presentation TCT 2016

TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Philip Green

October 31, 2016

Presentation TCT 2016

Rationale for and Design of COAPT: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Michael Argenziano, Alec S. Vahanian, Blase A. Carabello

October 31, 2016

Presentation TCT 2016

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

Presenter: Charles J. Davidson, Michael J. Reardon, James B. Hermiller Jr.

October 31, 2016

Presentation TCT 2016

Rationale for and Design of TAVR UNLOAD: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Michael Argenziano, Alec S. Vahanian, Daniel Burkhoff

October 31, 2016

Presentation TCT 2016

TCT 30: Safety, Clinical Performance and Multi-Modality Imaging Data of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with De Novo Lesions in Native Coronary Arteries at 12-Month Follow-Up-BIOSOLVE-II

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Michael Haude

October 31, 2016

Title Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presentation TCT 2016

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Suzanne Baron

October 31, 2016

Presentation TCT 2016

Rationale for and Design of GALILEO

Presenter: Michael Argenziano, Alec S. Vahanian, Paul Sorajja

October 31, 2016

Presentation TCT 2016

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

Presenter: Charles J. Davidson, Michael J. Reardon, James Harvey

October 31, 2016

Presentation TCT 2016

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

Presenter: Michael Argenziano, Alec S. Vahanian, Patrick T. O'Gara

October 31, 2016

News Conference News TCT 2016

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Todd Neale

October 31, 2016

Presentation TCT 2016

EVLA and RFA for Treatment of Lower Extremity Superficial Venous Disease

Presenter: Michael D. Dake, Michael R. Jaff, Sanjiv Lakhanpal

October 31, 2016

Presentation TCT 2016

Sclerotherapy and Non-Thermal Non-Tumescent Therapies for Treatment of Lower Extremity Superficial Venous Disease

Presenter: Michael D. Dake, Michael R. Jaff, Zvonimir Krajcer

October 31, 2016

Presentation TCT 2016

Latest Results on Catheter Assisted Thrombolysis and Thrombectomy for Submassive and Massive PE

Presenter: Michael D. Dake, Michael R. Jaff, Akhilesh K. Sista

October 31, 2016

Presentation TCT 2016

Featured Lecture: The Rationale and Impact of New European Device Regulations

Presenter: Michael J. Mack, Aaron V. Kaplan, Alan G. Fraser

October 31, 2016

Presentation TCT 2016

Complex Venous Intervention Case Presentation: Diagnosis and Treatment of May-Thurner Syndrome

Presenter: Michael D. Dake, Michael R. Jaff, Mark J. Goodwin, Constantino S. Pena

October 31, 2016

Presentation TCT 2016

Complex Venous Intervention Case Presentation: Diagnosis and Treatment of May-Thurner Syndrome

Presenter: Michael D. Dake, Michael R. Jaff, Mark J. Goodwin, Constantino S. Pena

October 31, 2016

Presentation TCT 2016

Valvular Heart Disease III: Mitral Stenosis, Pulmonic Stenosis, and Tricuspid Regurgitation

Presenter: Michael J. Lim, Payam Dehghani

October 31, 2016

Advertisement

TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

TCT 51: In-Hospital and One-Month Outcomes of 983 Patients Implanted With Bioresorbable Vascular Scaffolds for Acute Coronary Syndroms; Subgroup of the Prospective, All Comers, Controlled, Multicenter, FRANCE ABSORB Registry

TCT 50: Impact of a Bifurcation Culprit Lesion in ST Elevation Myocardial Infarction: Procedural Success, Clinical Outcome, and Five-Year Follow-up

TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial

Rationale for and Design of COAPT: What I Expect the Findings to Be But What Wont Surprise Me!

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

Rationale for and Design of TAVR UNLOAD: What I Expect the Findings to Be But What Wont Surprise Me!

TCT 30: Safety, Clinical Performance and Multi-Modality Imaging Data of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with De Novo Lesions in Native Coronary Arteries at 12-Month Follow-Up-BIOSOLVE-II

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Rationale for and Design of GALILEO

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

EVLA and RFA for Treatment of Lower Extremity Superficial Venous Disease

Sclerotherapy and Non-Thermal Non-Tumescent Therapies for Treatment of Lower Extremity Superficial Venous Disease

Latest Results on Catheter Assisted Thrombolysis and Thrombectomy for Submassive and Massive PE

Featured Lecture: The Rationale and Impact of New European Device Regulations

Complex Venous Intervention Case Presentation: Diagnosis and Treatment of May-Thurner Syndrome

Complex Venous Intervention Case Presentation: Diagnosis and Treatment of May-Thurner Syndrome

Valvular Heart Disease III: Mitral Stenosis, Pulmonic Stenosis, and Tricuspid Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content